# Clinical Study of Chemogenetic Gene Therapy With AAV for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus

> **NCT07533591** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 6 (estimated)

## Conditions studied

- Parkinson's Disease (PD)

## Interventions

- **GENETIC:** gene therapy

## Key facts

- **NCT ID:** NCT07533591
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2029-04
- **Final completion:** 2029-04
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07533591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07533591, "Clinical Study of Chemogenetic Gene Therapy With AAV for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07533591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*